JP2008509658A5 - - Google Patents

Download PDF

Info

Publication number
JP2008509658A5
JP2008509658A5 JP2007521793A JP2007521793A JP2008509658A5 JP 2008509658 A5 JP2008509658 A5 JP 2008509658A5 JP 2007521793 A JP2007521793 A JP 2007521793A JP 2007521793 A JP2007521793 A JP 2007521793A JP 2008509658 A5 JP2008509658 A5 JP 2008509658A5
Authority
JP
Japan
Prior art keywords
rhd
cells
cell
antibody
recombinant polyclonal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007521793A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008509658A (ja
JP4926054B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2005/000501 external-priority patent/WO2006007850A1/en
Publication of JP2008509658A publication Critical patent/JP2008509658A/ja
Publication of JP2008509658A5 publication Critical patent/JP2008509658A5/ja
Application granted granted Critical
Publication of JP4926054B2 publication Critical patent/JP4926054B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007521793A 2004-07-20 2005-07-18 抗−ＲｈＤ組換えポリクローナル抗体及び製造方法 Expired - Fee Related JP4926054B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA200401133 2004-07-20
DKPA200401133 2004-07-20
DKPA200401992 2004-12-22
DKPA200401992 2004-12-22
PCT/DK2005/000501 WO2006007850A1 (en) 2004-07-20 2005-07-18 Anti-rhesus d recombinant polyclonal antibody and methods of manufacture

Publications (3)

Publication Number Publication Date
JP2008509658A JP2008509658A (ja) 2008-04-03
JP2008509658A5 true JP2008509658A5 (OSRAM) 2008-07-03
JP4926054B2 JP4926054B2 (ja) 2012-05-09

Family

ID=35159789

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007521793A Expired - Fee Related JP4926054B2 (ja) 2004-07-20 2005-07-18 抗−ＲｈＤ組換えポリクローナル抗体及び製造方法

Country Status (13)

Country Link
US (2) US8198415B2 (OSRAM)
EP (2) EP1967529A1 (OSRAM)
JP (1) JP4926054B2 (OSRAM)
KR (1) KR20070038556A (OSRAM)
AU (1) AU2005263331B8 (OSRAM)
BR (1) BRPI0513706A (OSRAM)
CA (1) CA2574062A1 (OSRAM)
EA (1) EA014182B1 (OSRAM)
IL (1) IL179658A (OSRAM)
MX (1) MX2007000644A (OSRAM)
NO (1) NO20070927L (OSRAM)
NZ (1) NZ552265A (OSRAM)
WO (1) WO2006007850A1 (OSRAM)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7658924B2 (en) 2001-10-11 2010-02-09 Amgen Inc. Angiopoietin-2 specific binding agents
NZ541458A (en) * 2003-01-07 2006-04-28 Symphogen As Method for manufacturing recombinant polyclonal proteins
AR045563A1 (es) 2003-09-10 2005-11-02 Warner Lambert Co Anticuerpos dirigidos a m-csf
TWI333977B (en) * 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
CA2574146C (en) 2004-07-20 2015-06-30 Symphogen A/S A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line
AU2006322445B2 (en) 2005-12-05 2011-05-12 Symphogen A/S Anti-orthopoxvirus recombinant polyclonal antibody
TW200846362A (en) * 2007-02-09 2008-12-01 Symphogen As A polyclonal antibody product
ATE521704T1 (de) * 2007-03-01 2011-09-15 Symphogen As Verfahren zur klonierung verwandter antikörper
KR101805140B1 (ko) 2007-03-01 2017-12-05 심포젠 에이/에스 재조합 항-표피 성장 인자 수용체 항체 조성물
WO2008106980A2 (en) * 2007-03-06 2008-09-12 Symphogen A/S Recombinant antibodies for treatment of respiratory syncytial virus infections
JP2008289483A (ja) * 2007-05-25 2008-12-04 Symphogen As 真核生物系において発現可能な形質転換体のスクリーニング
MX2009012526A (es) * 2007-05-25 2009-12-09 Symphogen As Metodo para fabricar una proteina policlonal recombinante.
KR20100087283A (ko) * 2007-09-07 2010-08-04 심포젠 에이/에스 항­ｒｓｖ 항체의 재조합 제조 방법
US20090093004A1 (en) * 2007-10-04 2009-04-09 Symphogen A/S Potency assay
CA2702322A1 (en) * 2007-11-22 2009-05-28 Symphogen A/S A method for characterization of a recombinant polyclonal protein
JO2913B1 (en) 2008-02-20 2015-09-15 امجين إنك, Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
NZ717429A (en) * 2008-04-11 2018-07-27 Chugai Pharmaceutical Co Ltd Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
RU2010147652A (ru) * 2008-04-23 2012-05-27 Симфоген А/С (Dk) Способы производства поликлонального белка
AR072999A1 (es) 2008-08-11 2010-10-06 Medarex Inc Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos
TW201012477A (en) * 2008-08-26 2010-04-01 Symphogen As Treatment of thrombocytopenia
RU2540146C2 (ru) 2008-08-29 2015-02-10 Симфоген А/С Композиции рекомбинантных антител против рецептора эпидермального фактора роста
EP2331689A4 (en) * 2008-08-29 2012-10-31 Symphogen As METHOD OF CLONING AVIAN ORIGIN ANTIBODIES
US20110224094A1 (en) * 2008-10-06 2011-09-15 Symphogen A/S Method for identifying and selecting drug candidates for combinatorial drug products
FR2942799B1 (fr) * 2009-03-06 2011-02-25 Lfb Biotechnologies Anticorps monoclonal anti-rhesus d
CN102687020A (zh) 2009-10-09 2012-09-19 西福根有限公司 利用特征肽和质谱对混合物中的单个重组蛋白进行多重定量
CN112812184A (zh) 2011-02-25 2021-05-18 中外制药株式会社 FcγRIIb特异性Fc抗体
US9845338B2 (en) * 2012-06-21 2017-12-19 Synthon Biopharmaceuticals Bv Method of purifying an antibody
EP2711428A1 (en) 2012-09-21 2014-03-26 Lonza Biologics plc. Site-specific integration
UY34887A (es) 2012-07-02 2013-12-31 Bristol Myers Squibb Company Una Corporacion Del Estado De Delaware Optimización de anticuerpos que se fijan al gen de activación de linfocitos 3 (lag-3) y sus usos
PL3508502T3 (pl) 2013-09-20 2023-07-17 Bristol-Myers Squibb Company Kombinacja przeciwciał anty-lag-3 i przeciwciał anty-pd-1 w leczeniu raka
JOP20200094A1 (ar) 2014-01-24 2017-06-16 Dana Farber Cancer Inst Inc جزيئات جسم مضاد لـ pd-1 واستخداماتها
LT3116909T (lt) 2014-03-14 2020-02-10 Novartis Ag Antikūno molekulės prieš lag-3 ir jų panaudojimas
US9683017B2 (en) 2014-07-17 2017-06-20 University Tennessee Research Foundation Inhibitory peptides of viral infection
WO2016032949A1 (en) 2014-08-26 2016-03-03 University Of Tennessee Research Foundation Targeting immunotherapy for amyloidosis
WO2017184973A1 (en) 2016-04-22 2017-10-26 University Of Tennessee Research Foundation Identifying amyloidogenic proteins & amyloidogenic risk
CN118356488A (zh) 2017-05-30 2024-07-19 百时美施贵宝公司 包含抗lag-3抗体或抗lag-3抗体和抗pd-1或抗pd-l1抗体的组合物
PT3631454T (pt) 2017-05-30 2023-11-23 Bristol Myers Squibb Co Tratamento de tumores positivos para lag-3
MA52945A (fr) * 2018-06-22 2021-04-28 Genmab As Procédé de production d'un mélange contrôlé d'au moins deux anticorps différents
EP3870604B1 (en) 2018-10-26 2022-11-23 F. Hoffmann-La Roche AG Multispecific antibody screening method using recombinase mediated cassette exchange
AU2020253023B2 (en) 2019-03-29 2022-07-14 F. Hoffmann-La Roche Ag Method for the generation of an FcRn expressing cell by targeted integration of multiple expression cassettes in a defined organization
WO2020205775A1 (en) * 2019-03-29 2020-10-08 H. Lee Moffitt Cancer Center And Research Institute, Inc. Antibodies against programmed cell death protein 1 (pd1) and uses thereof
CN114008081A (zh) 2019-06-19 2022-02-01 豪夫迈·罗氏有限公司 通过以限定的组织形式靶向整合多个表达盒来产生二价双特异性抗体表达细胞的方法
MX2021015537A (es) 2019-06-19 2022-02-10 Hoffmann La Roche Metodo para la generacion de una celula que expresa anticuerpo biespecifico multivalente mediante la integracion diana de casetes de expresion multiples en una organizacion definida.
AU2020294878A1 (en) 2019-06-19 2021-12-23 F. Hoffmann-La Roche Ag Method for the generation of a multivalent, multispecific antibody expressing cell by targeted integration of multiple expression cassettes in a defined organization
MX2021015540A (es) 2019-06-19 2022-02-10 Hoffmann La Roche Metodo para la generacion de una celula que expresa un anticuerpo trivalente mediante la integracion dirigida de multiples casetes de expresion en una organizacion definida.
WO2020254357A1 (en) 2019-06-19 2020-12-24 F. Hoffmann-La Roche Ag Method for the generation of a protein expressing cell by targeted integration using cre mrna
WO2022150654A2 (en) * 2021-01-08 2022-07-14 10X Genomics, Inc. Antigen-binding polypeptides specific for coronaviruses and uses thereof
RU2770654C1 (ru) * 2021-06-17 2022-04-20 Федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургский государственный педиатрический медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПбГПМУ Минздрава России) Способ профилактики тяжелой формы гемолитической болезни новорожденных при резус-иммунизации у беременных с соматической патологией и потерями плода в анамнезе
WO2025039046A1 (en) * 2023-08-23 2025-02-27 The Walter And Eliza Hall Institute Of Medical Research Anti-rhesus d human monoclonal antibodies
CN119176879B (zh) * 2024-09-05 2025-08-05 西安市中心血站（陕西省血液中心） 一种中和抗d抗体的抗独特型抗体及其应用

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002413A1 (en) 1983-11-28 1985-06-06 The Board Of Trustees Of The Leland Stanford Jr. U HUMAN MONOCLONAL ANTIBODY AGAINST Rh(D) ANTIGEN AND ITS USES
US5126130A (en) * 1986-11-24 1992-06-30 The Childrens Hospital Incorporated Monoclonal antibodies reactive with specific antigenic sites on human cytomegalovirus glycoprotein a
GB8722020D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722018D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722019D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
WO1990005144A1 (en) 1988-11-11 1990-05-17 Medical Research Council Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
GB8906129D0 (en) 1989-03-17 1989-05-04 Central Blood Lab Authority Pharmaceutical preparations
GB8919761D0 (en) 1989-09-01 1989-10-18 Central Blood Lab Authority Chemical compounds
WO1992015694A1 (en) 1991-03-08 1992-09-17 The Salk Institute For Biological Studies Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor
US5837268A (en) 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
PL302438A1 (en) 1992-06-26 1994-07-25 Aetsrn Human anti-rh(d) monoclonal antibodies and cellular lines producing them
EP1324040A3 (en) 1992-10-21 2007-06-20 MILTENYI, Stefan Direct selection of cells by secretion product
US5538848A (en) * 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
PT1231268E (pt) * 1994-01-31 2005-11-30 Univ Boston Bancos de anticorpos policlonais
FR2724182B1 (fr) * 1994-09-02 1996-12-13 Pasteur Institut Obtention d'un anticorps monoclonal recombinant a partir d'un anticorps monoclonal humain anti-rhesus d, sa production en cellules d'insecte, et ses utilisations
US6025155A (en) 1996-04-10 2000-02-15 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US7038020B1 (en) 1996-06-24 2006-05-02 Zlb Behring Ag Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use
US6255455B1 (en) * 1996-10-11 2001-07-03 The Trustees Of The University Of Pennsylvania Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof
US5876925A (en) * 1996-10-11 1999-03-02 The Trustees Of The University Of Pennsylvania Magnetically activated cell sorting for production of proteins
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
AU760113C (en) 1997-11-18 2004-04-22 Pioneer Hi-Bred International, Inc. Compositions and methods for genetic modification of plants
WO2000005393A2 (en) 1998-07-21 2000-02-03 Cobra Therapeutics Limited A polynucleotide comprising a ubiquitous chromatin opening element (ucoe)
US20020155114A1 (en) * 1998-08-31 2002-10-24 James D. Marks Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
WO2001007572A2 (en) 1999-07-23 2001-02-01 The Regents Of The University Of California Dna recombination in eukaryotic cells by the bacteriophage phic31 recombination system
EP1106625A1 (en) 1999-11-17 2001-06-13 ZLB Bioplasma AG Rhesus D specific peptide sequences
JP2004500567A (ja) 2000-02-08 2004-01-08 ザ　リージェンツ　オブ　ザ　ユニバーシティ　オブ　ミシガン タンパク質分離および提示
EP1385869A2 (en) 2000-02-08 2004-02-04 The Regents Of The University Of Michigan Protein mapping
US7069151B2 (en) 2000-02-08 2006-06-27 Regents Of The University Of Michigan Mapping of differential display of proteins
AU6206701A (en) 2000-05-26 2001-12-03 Symphogen As Recombinant or purified polyclonal antibodies for treating allergy
JP2004504055A (ja) 2000-07-21 2004-02-12 アメリカ合衆国 真核生物ゲノムにおけるｄｎａの置換、転座およびスタッキングの方法
US6610472B1 (en) 2000-10-31 2003-08-26 Genetastix Corporation Assembly and screening of highly complex and fully human antibody repertoire in yeast
CA2430080A1 (en) * 2000-11-28 2002-06-06 Applied Molecular Evolution, Inc. Eukaryotic expression libraries based on double lox recombination and methods of use
ATE475092T1 (de) 2000-12-26 2010-08-15 Inst Systems Biology Schnelle und quantitative proteomanalyse und entsprechende verfahren
US20040033591A1 (en) 2002-05-31 2004-02-19 The Regents Of The University Of Michigan Automated protein analysis system
SI1523496T1 (sl) 2002-07-18 2011-11-30 Merus B V Rekombinantno proizvajanje zmesi protiteles
US20040137526A1 (en) 2002-10-15 2004-07-15 The Regents Of The University Of Michigan Multidimensional protein separation system
US20060275766A1 (en) * 2003-01-07 2006-12-07 Haurum John S Method for manufacturing recombinant polyclonal proteins
NZ541458A (en) * 2003-01-07 2006-04-28 Symphogen As Method for manufacturing recombinant polyclonal proteins
TWI333977B (en) * 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
CA2574146C (en) 2004-07-20 2015-06-30 Symphogen A/S A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line

Similar Documents

Publication Publication Date Title
JP2008509658A5 (OSRAM)
DE60106394T3 (de) Humanisierte antikörper, die amyloid beta peptid sequestrieren
CN107207594B (zh) 针对tigit的抗体
EP3042917B1 (en) Anti-n3pglu amyloid beta peptide antibodies and uses thereof
CN1703426B (zh) 识别β-淀粉样肽的人源化抗体
TWI307716B (en) Dual specificity antibodies and methods of making and using
TWI264467B (en) Human anti-CD40 antibodies and methods of making and using same
CN1798766B (zh) 识别β-淀粉样肽的人源化抗体
TWI223666B (en) Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
US8519112B2 (en) Humanized antibodies against monocyte chemotactic proteins
US8597615B2 (en) Methods of monitoring a human anti-human antibody response and inhibitors thereof
US8956607B2 (en) Humanized anti-IL 10 antibodies for the treatment of systemic lupus erythematosus (SLE)
AU2018271353A1 (en) Antibodies recognizing alpha-synuclein
TW201731878A (zh) 使用胃抑肽受體（gipr）結合蛋白與glp-1促效劑之組合來治療或改善代謝病症之方法
CN110023335A (zh) 抗-pd-1抗体、其生产方法及其使用方法
CN107567460A (zh) Fcrn抗体及其使用方法
CN107771184A (zh) 针对cd40的抗体
KR20160091457A (ko) Ｒｇｍ ａ 단백질에 대한 모노클로날 항체 및 이의 용도
EA028899B1 (ru) АНТИ-C5a-АНТИТЕЛА И СПОСОБЫ ПРИМЕНЕНИЯ АНТИТЕЛ
SG192496A1 (en) Prostaglandin e2 binding proteins and uses thereof
AU3369701A (en) Antibodies to human il-1beta
CN107207588A (zh) 针对tau的抗体和其用途
TW201425337A (zh) 人化抗ｃｘｃｒ５抗體類、彼之衍生物類及彼等之用途
CN104507968A (zh) 人cd30配体抗原结合蛋白
CN104974250A (zh) 抗il-17f抗体及其使用方法